Clinical Trial

Clinical Outcomes and Patient Satisfaction With Velnez Versus Nasopore in Nasal Surgery

Completed
View on ClinicalTrials.gov →
Summary
This clinical trial evaluated two absorbable nasal packing materials - VELNEZ and NASOPORE - in adult patients (18-70 years) who underwent nasal surgery, including septoplasty, FESS, or turbinoplasty. The study addressed two core questions: whether VELNEZ offered superior haemorrhage control and faster biodegradation, and whether it reduced postoperative pain, fibrosis, adhesion, and discomfort compared to NASOPORE. Participants were randomised to receive either packing material following surgery. They were monitored on the day of surgery for haemostasis and device performance, then followed up with clinical and endoscopic assessments - including pain scoring and adverse event tracking - through Day 90.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-24.
Trial Details
NCT Number NCT07560254
Lead Sponsor Ayu, Inc.
Conditions Rhinosinusitis, Sinusitis, Chronic Rhino-sinusitis
Enrollment 20 participants
Start Date 2024-09-11
Primary Completion 2025-04-11 (estimated)
Study Completion 2025-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-06